logo

Novartis Ag (NVS)



Trade NVS now with
  Date
  Headline
6/23/2022 1:06:08 AM Novartis To Invest $250 Mln Over 5 Yrs To Advance R&D Of New Treatments Against NTDs And Malaria
6/23/2022 1:04:13 AM Novartis: FDA Approves Tafinlar + Mekinist For First Tumor-agnostic Indication For BRAF V600E Solid Tumors
6/17/2022 1:31:28 AM Sandoz: EMA Accepts Application For Proposed Biosimilar Adalimumab's High Concentration Formulation
6/7/2022 11:02:36 AM Novartis Scemblix Shows Superior, Consistent Tolerability In 96-week Of Chronic Myeloid Leukemia Trial
6/6/2022 9:38:24 AM Novartis :Tafinlar + Mekinist Shows Efficacy In Pediatric Patients With BRAF V600 Low-grade Gliomas
5/31/2022 1:24:25 AM Sandoz Announces Launch Of New Global Initiative Called 'Act4Biosimilars'
5/12/2022 10:53:38 AM Novartis Highlights Data From Across Its Oncology Portfolio
4/26/2022 1:02:12 AM Novartis Q1 EPS $1.00; Core EPS $1.46